A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Telik Inc.

About Telik Inc.

Telik, Inc. (Nasdaq: TELK) of Palo Alto, CA is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases.

The Company discovered all of its product candidates using its proprietary technology, Target-Related Affinity Profiling (TRAP).

Their most advanced product is TELCYTA™ (TLK286), a novel cancer cell-activated chemotherapeutic currently in three Phase 3 registration trials in advanced ovarian cancer and non-small cell lung cancer. A second development candidate, TELINTRA™ (TLK199), is in a Phase 2 clinical trial in myelodysplastic syndrome and may also have utility in the treatment of chemotherapy-induced cytopenia.




TELCYTA --advanced ovarian cancer and non-small cell lung cancer

TELINTRA myelodysplastic syndrome



More About Telik

Home Page

Key Statistics for Telik

Basic Chart for Telik

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.